PolyNovo Biomaterials Pty Ltd. is the developer and owner of a unique biodegradable polymer – NovoSorb™. It was founded in 1998 in Port Melbourne, Australia where the international headquarters resides, and has expanded into the US market.

PolyNovo develops Regenerative Devices for reconstructive surgery and tissue repair with our patented biodegradable polymer technology, NovoSorb – a family of medical grade polymers used to form medical devices to reconstruct or repair failed tissue. NovoSorb can be tailored to a desired strength, elasticity or degradation profile and has significant advantages in terms of safety, toxicology profile and strength. The NovoSorb polymer can be made into Dermal Matrix, implantable devices and other regenerative devices.

PolyNovo NovoSorb™ Dermal Matrix

NovoSorb™ BTM (Biodegradable Temporizing Matrix) was developed with our innovative polymer technology providing physicians a clinically proven matrix for partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic and vascular ulcers, surgical wounds, trauma wounds and draining wounds.

Interview with Andrew Bollhoefer

Vice President, US Sales

Opportunities Highlights

Account Executive


PolyNovo's US Leadership Team

Our US leadership team has a combined total of over 150 years of Sales and Marketing experience with expertise in burn, trauma, orthopedics, wound care management, reconstruction, biologics, supply chain, GPO/IDN contracting, and regenerative medicine.

PolyNovo US Sales Leaders (3)

PolyNovo Team in Action